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immunodeficiency. The pneumonias may be primarily viral, bacte- 
rial/fungal, or mixed. RSV has been associated with an exceptionally 
high frequency of the progression to fatal viral pneumonia in some 
subsets of patients. The mortality of untreated RSV pneumonia in 
these patients has been > 80%. Studies have suggested that the early 
initiation of therapy with a combination of aerosolized ribavirin and 
M G  may be of benefit. Influenza has been associated with a some- 
what lower frequency of progression to f a d  wal pneumonia than 
RSV, however, the spectrum of vulnerable patients has been broader. 
Because of the large number of immunocompromised patients seri- 
ously ill with CRV diseases, effective prophylactic and therapeutic 
regimens need to be defined expeditiously. This will be a challenge 
given the diversity of viruses and their widespread prevalence and 
contagiousness; the lirmted means of rapid dqnosis; the paucity 
of prophylactic and therapeutic options; and the wide spectrum of 
immunocompromised patients with varying vulnerability to serious 
CRV disease. 
I S 197 I Risk assessment and response in suspected 
imported cases of viral haemonhagic fevers 
D. Bennett. Communicable Disease Surwillance Cenhe, London, UK 
V d  hemorrhagic fevers (VHF) are infkquently seen outside their 
countries of origin, but cases have occasionally been imported into 
Europe, the U.S., Oceania, and recently South Africa. During the 
period of an outbreak in the country of origin, other countries 
may experience panic, inappropriate responses by officials and others 
dealing with well and ill immigrants/traders, delays in diagnosis 
and treatment of patients with other &eases, and unnecessary lab- 
oratory tests, isolation, and surveillance procedures in misclassified 
suspect cases. Over 95% of suspected imported VHF cases have had 
a final dqnosis of malaria. On the other hand, unclear or nonexis- 
tent policies can also lead to lack of communication between public 
health personnel, infectious disease physicians, microbiologists, im- 
migration officials, and the public, and to delays in ordering appro- 
priate tests, isolation, treatment, and surveillance of contacts when 
a VHF should be suspected. Policies should ensure coordinated ef- 
forts for prompt recognition of suspected cases leading to appropriate 
clinical, laboratory, transport, public health, and media responses, but 
also for prevention of inappropriate suspicion and responses. 
Specific guidance has been developed in the U.K. for management 
and control of VHF, focusing on those that are trammissible person 
to person. Policy areas include risk assessment, patient management, 
specimen handling, laboratory procedures, and public health actions. 
The discussion will focus on this guidance and examples of U.K. 
coordinated actions to deal with the possibility of imported cases 
during recent outbreaks of VHF in Atiica. It is suggested that coun- 
tries should consider communication procedures to coordinate the 
work of clinical personnel with other sectors. It is useful for all hos- 
pitals to have policies known to all relevant staff for the management 
of patients with a pyrexia of unknown origin or a suspected VHF, 
and procedures for communication with public health officials, spe- 
ualist clinicians and laboratories, and high security infectious disease 
units when appropriate. Cases in which a VHF is to be ruled out 
can be classified by "risk category", and suggested procedures will 
be discussed for each level of risk. Basic patient information to be 
collected will be listed, and flow charts for handling of patients and 
specimens based on risk category will be set out. 
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I S198 I Emergence of Internationally-Spread 
Multidrug-Resistant (MDR) Clones of 
Streptococcus pneumoniae 
A. Tomasz. The Rockefeller Unim'ty, Nk; Nk; USA 
I shall discuss three aspects of MDR pneumococci. (i) The "biolog- 
ical price" of resistance. Laboratory mutants of pneumococci with the 
same basic molecular mechanism of penicillin resistance as the one 
identified in resistant isolates recovered fiom the clinical environ- 
ment have a multiplicity of physiologicalhiochemical defects which 
are absent fiom the clinical resistant bugs. New experiments have 
begun to rhrow some light on the nature of these extra "fimess" 
factors present in clinical isolates (but not in laboratory mutants) of 
resistant pneumococd that allow expression of antibiotic resistance 
without jeopardizing normal physiology. (ii) Acquisition and exchange 
ofgenetic material will be dustrated by results documenting the ubiq- 
uitous presence of competence (for genetic transformation) genes 
within the species, and by new experiments documenting in vivo 
exchange of capsular genes in MDR pneumococci. (iii) Properties 
of 3 internationally-spread MDR clones of S. pneumoniae will be 
summarized includmg clone-spec& properties such as the structure 
of the resistant PBP genes; unique protein polymorphism of PBPs, 
unique chromosomal macrorestriction fingerprints and unique cell 
wall composition. An update on the geographic expansion of these 
international clones will be provided fiom prevalence data that in- 
clude both invasive as well as colonizing isolates. 
I S199 I Genomic Analysis of Streptococcuspneumoniae 
P Matsushima, R.H. Balm, E Norris, B.S. DeHoff, F! R o c k ,  
G. Porter, S. Burgett, R. Peery, J. Hoskins, L. Braverman, 
I. Jenkins, F! Solenberg, M. Young-Behdo, M. Mdienney, J. Tang, 
EL. Skatrud, PR. Rosteck, S.R. Jaskunas. f i l ly Research Laboratories, 
Eli fi l ly G Co.,  Indiana 46285, USA 
Effective therapy for upper-respiratory infections has become 
compromised in recent years by the emergence of strains that are 
resistant to commonly used antibiotics such as penicillin. In partic- 
ular, the wide-spread occurrence of penicillin-resistant Streptocm 
pneumonia has become a major concern. To discover new antibiotics 
that could be used to treat these infections we have initiated a 
project to identlfy novel targets in S. pneumoniae that are also found 
in other organisms responsible for upper-respiratory infections 
such as Haemophilus infuenzae. Possible targets are being identified 
by random DNA sequence analysis of the S. pneumoniae genome. 
Sample sequencing has been used to idenafy genes, which have been 
mapped to different Smd m e n 6  of the c d a r  chromosome 
and compared to orthologous genes in other organisms. I n r e d  
segments of the genes are being used for insertional mutagenesis 
to determine if any particular gene is required for viability. An 
unconventional procedure was developed for these 'knock-out' 
experiments, which will be described along with the results of the 
sequence analysis. 
I s200 I The EfFect of Antimicrobial Use on the 
Epidemiology of Penicillin Resistant 
Pneumococci in Children 
K.G. Kritinsson. National University Hospital, Reykjavik, Iceland 
P e n i c h  resistant and multiresistant pneumococci have spread glob- 
ally and reached high predence rates in many countries. Antimi- 
crobial use is considered to be a major driving force for resistance in 
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hospitals, but the influence in the community has not been as clearly 
demonstrated. Only with a clear understandmg of all the risk factors 
involved, can effective control measures be introduced. 
The main habitat of the pneumococcus is the nasopharynx of 
chddren and antimicrobial use in chlldren is therefore likely to have 
a significant d u e n c e  on the susceptibility of pneumococci. Re- 
cent studies investigating risk factors for resistance in pneumococci 
have identified antimicrobial use as a risk factor; especially ongo- 
ing, recent, repeated, kequent, and prophylactic use. The effect of 
individual antimicrobial classes has not been studied in detail, but 
use of p-lactam antibiotics and sulpha-trirnethoprim has been asso- 
ciated with increased risk. Day-care centres can facilitate the spread 
of resistant pneumococci, and carriage of resistant pneumococci in 
Iceland was associated with young age, domicile in an area with high 
antimicrobial consumption, recent antimicrobial use, kequent an- 
timicrobial use and use of trimethoprim-sulpha. Other studies have 
also shown a correlation between antimicrobial usage in ditferent 
areas and antimicrobial resistance. 
Reduction of antimicrobial use in Iceland, with subsequent re- 
duced incidence of p e n i c h  resistant pneumococci, may indicate a 
cause and an effect, and should stimulate programs aimed at prudent 
antimicrobial use. 
isolates contain mosaic pbp2x genes where parts are replaced by ho- 
mologous sequences from related species. Mosaic homologues of 
pbp2x are present in penicillin sensitive S. mitis and S. oralis, demon- 
strating that transfer of pbpZx sequences has occurred independent 
on resistance to p e n i c h .  Transfer of pbp2x genes between suscep- 
tible species could indeed be observed under laboratory conditions. 
One class of pbp2x with a high degree of s d a r i t y  to the S. oralis 
pbp2x were found in resistant strains of Merent biovars of S.mitis and 
S. oralis, and major clones of S. pneumoniae from Merent countries 
and even continents. Sequence comparison documents that at least 
another two species participate in the genetic exchange of resistance 
determinants. The data obtained raise the question on the defini- 
tion of species-speclfic sequences for selectable markers in naturally 
transformable bacteria. 
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(s2011 Treatment Options in Resistant Pneumococcal 
Infections 
R. Pallares. Hospital de Bellvifge, University of Barcelona, Spain 
Over the past three decades penicillin-resistant pneumococci 
have emerged worldwide. In addition, penicih-resistant strains 
have also decreased susceptibhty to other be t a - l ace  (including 
cephalosporins) and these strains are often resistant to other antibiotic 
groups, making the treatment options much more ditficult. Never- 
theless, the present in vitro definitions of resistance to penicillin and 
cephalosporins in pneumococci could not be appropriated for all 
types of pneumococcal mfections. Thus, current levels of resistance 
to penicillin and cephalosporin seem to have little, ifany, clinical rel- 
evance in nonmeningeal infections (eg. pneumonia or bacteremia). 
On the contrary, numerous dinical failures have been reported in 
patients with pneumococcal meningitis caused by strains with peni- 
cillin MIC p 0.12 fig/ml, and penicillin should never be used in 
pneumococcal meningitis except when the strain is known to be 
fully susceptible to this drug. Nowadays, therapy for pneumococcal 
meningitis should mainly be selected on the basis of susceptibility 
to cephalosporins, and most patients may currently be treated with 
high dose cefotaxime (f) vancomycin, depending on the levels of 
resistance in the patient’s geographic area. However, it should be em- 
phasized that the most appropriate antibiotic therapy for infections 
caused by resistant pneumococci remains controversial, and compar- 
ative, randomized stumes are urgently needed in order to clarlfy the 
best antibiotic therapy for these infections. We will present a practical 
approach, based on current levels of antibiotic resistance, for treating 
the most prevalent pneumococcal mfections. 
Global epidemiology of the PBP2x gene of 
penicillin-resistant pneumococci 
R. Hakenbeck, A. Konig, P. Reichmann. Mar-Planck Inztitutfut 
Molekulare Genetik, Berlin 
Penicillin-binding proteins (PBPs) functioning as selectable resistance 
determinants can be used to investigate the number of species con- 
tributing to a gene pool that is accessible for a pathogen such as 
Streptococcus pneumoniae. PBP2x is one of the primary penicillin re- 
sistance determinants in S. pneumoniae, and all penich-resistant 
S203 I Bloodborne Pathogens: Update on 
post-exposure management and prophylaxis 
D.M. Bell. Centersfor Disease Confrol and Prevention, Atlanta, G A ,  
U S A  
In 1996, the U.S. Public Health Service recommended post-ex- 
posure prophylaxis (PEP) after certain occupational HIV exposures 
(MMWR 1996); 45: 468-72). This recommendation was based in 
part on a case-control study of health-care workers exposed to HIV 
in the USA and Europe in which zidovudine PEP was associated with 
an approximately 80% reduction in risk of seroconversion (MMWR 
1995; 44: 929-33). CDC has received many inquiries, e.g., concern- 
ing implementation, use ofnewly licensed drugs for PEP, and possible 
use ofPEP for sexual exposures. Periodic updates are expected; a ma- 
jor a c u l t y  is h t e d  data on toxicity and efficacy of PEP. 
For hepatitis C virus (HIV), no PEP is available. Evaluation of 
workers with percutaneous or mucosal exposure to blood from 
source patients positive for anti-HCV might include 6-month fol- 
low-up testing of the exposed worker for anti-HCV and serum 
alanine amino transferase (ALT) activity. All repeatedly reactive tests 
by EL4 should be confirmed by supplemental anti-HCV testing. 
I S204 I The pregnant health-care worker: are special 
A.L. Panlil~o. Centersfor Disease Control and Revention, Atlanta, G4, 
USA 
Immunologic changes that occur during pregnancy generally do not 
increase susceptibility to infectious diseases. Nevertheless, nosoco- 
mul transmission of certain infections may be of particular concern 
to pregnant health-care workers for a variety of reasons. Some infec- 
tions, such as varicella, may be more severe during pregnancy. 
Transplacental infection with viruses such as parvovirus, varicella, 
and rubella has been associated with abomon, congenital anomaly, 
and/or mental retardation. Finally, certain drugs used to treat or 
prevent some infections, e.g., tuberculosis, may be contraindicated 
during pregnancy. Pre-employment screening followed by appropri- 
ate immunizations can prevent many infections in health-care work- 
ers, pregnant or not. Further, careful adherence to infection control 
practices should minimize occupational exposures and nosocomial 
infections in pregnant health-care workers. 
precautions necessary? 
